Iovance interim CEO exercises options for 200,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
At Iovance Biotherapeutics, Inc., director and Interim CEO & General Counsel Frederick G. Vogt exercised a fully vested stock option on November 11, 2026, covering 200,000 common shares at an exercise price of $7.55 per share. The option was scheduled to expire November 14, 2026. The issuer withheld 186,651 shares for the exercise price and 4,652 for mandatory tax withholding; no shares were sold in the open market. The exercise increased Vogt's holdings by 8,697 shares and produced no cash proceeds.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F4 | 200,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 200,000 | $7.55 | $1.51M |
| Exercise Price or Tax Liability | Common Stock F2, F3 | 191,303 | $8.09 | $1.55M |
Footnotes (4)
- F1. Represents shares acquired upon the exercise of a stock option granted on November 14, 2016 covering 200,000 shares of the Issuer's common stock at an exercise price of $7.55 per share. The option was scheduled to expire on November 14, 2026. The Reporting Person exercised the option because of its impending expiration, during an open trading window, and did not receive any cash proceeds from the exercise. The net result of the exercise was an increase of 8,697 shares in the Reporting Person's holdings of the Issuer's common stock.
- F2. Represents shares withheld by the Issuer in a net exercise of the option, consisting of 186,651 shares withheld to pay the exercise price of the option and 4,652 shares withheld to satisfy the mandatory tax withholding requirements upon exercise of the option, in each case valued at the closing price of the Issuer's common stock on the transaction date. No shares were sold in the open market. This is not an open market sale of securities.
- F3. Represents common stock remaining after deducting the common stock withheld for the exercise price and taxes.
- F4. The option was fully vested and exercisable as of the transaction date.
Key Figures
Key Terms
net exercise financial
fully vested financial
open trading window technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did IOVA's interim CEO exercise the stock option?
AI-generated analysis. How Rhea-AI works. Not financial advice.